George McMillan Fleming Center for Law and Innovation Tech Transfer Tidbits: Apr 22, 2009 Premium Merck, Medarex, and UMass' MBL Ink mAb deal; Vandy licenses cancer Rx assay to DiaTech; MolecularMD sub-licenses OHSU CML mutation test to Mayo Clinic, and more … Breaking News Brain Cancer Study Reveals Immune Cell Populations Linked to Aggressive Subtype US Government Places Export Controls on LC-MS Instruments for Top-Down Proteomics Guardant Health, ConcertAI Partner on Combined Clinicogenomic Data-as-a-Service Offering JP Morgan Healthcare Conference, Day 3: Grail, Ultima Genomics, Seer, GeneDx, Quanterix Caris Life Sciences, Ontada Ink Deal to Integrate Genomic, Clinical Cancer Data
